ICD-10-CM Billable Code

E34.51

Complete androgen insensitivity syndrome

Clinical Classification Guidelines

Inclusion Terms

  • Complete androgen insensitivity
  • de Quervain syndrome
  • Goldberg-Maxwell syndrome

Medical Intelligence & Overview

Complete Androgen Insensitivity Syndrome (AIS), classified under ICD-10 code E34.51, is a condition that affects the development of males' reproductive organs and physical traits. Individuals with this syndrome are genetically male but develop female characteristics due to the body's inability to respond to androgens, the hormones responsible for male traits. This condition typically presents during puberty and can influence physical development, reproductive health, and hormonal balance. It's a rare condition that requires awareness and understanding to support affected individuals effectively.

Causes & Symptoms

Clinical Causes: Mutations in the androgen receptor gene on the X chromosome Genetic inheritance from carrier parents Disrupted function of androgen receptors, preventing hormonal signals from working properly

Key Symptoms: Lack of pubic and underarm hair development Absence of menstrual periods (amenorrhea) Undescended testes located within the abdomen or pelvis Typical female external genitalia, including a vaginal canal No development of secondary sexual characteristics such as breast growth Potential for tall stature and a more pliable build

Diagnostic & Treatment

Diagnosis Path: Physical examination to assess external genitalia and secondary sexual characteristics Hormonal testing to measure levels of testosterone, luteinizing hormone, and other sex hormones Genetic testing to identify mutations in the androgen receptor gene Ultrasound or MRI scans to locate undescended testes Karyotype analysis revealing 46,XY chromosomal pattern despite female phenotype

Treatment Protocols: Psychosocial support and counseling to help individuals understand their condition Surgical intervention to remove undescended testes, which may carry a small risk of developing into cancer Hormonal therapy to support puberty and secondary sexual characteristic development if desired Regular monitoring for potential health concerns related to gonadal tissue Long-term healthcare planning that respects the individual's gender identity and personal preferences

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E34.51 a billable ICD-10 code?
Yes, E34.51 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E34.51?
Clinical documentation must specify the nature of Complete androgen insensitivity syndrome and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

androgen insensitivity complete syndrome